WallStSmart

Amphastar P (AMPH)vsViatris Inc (VTRS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Viatris Inc generates 1875% more annual revenue ($14.73B vs $745.79M). AMPH leads profitability with a 13.3% profit margin vs -4.1%. AMPH appears more attractively valued with a PEG of 2.77. AMPH earns a higher WallStSmart Score of 65/100 (C+).

AMPH

Buy

65

out of 100

Grade: C+

Growth: 8.0Profit: 6.5Value: 6.0Quality: 7.0
Piotroski: 3/9Altman Z: 2.23

VTRS

Hold

40

out of 100

Grade: D

Growth: 2.0Profit: 3.5Value: 3.0Quality: 5.0
Piotroski: 4/9Altman Z: 0.55
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMPHUndervalued (+28.3%)

Margin of Safety

+28.3%

Fair Value

$39.87

Current Price

$29.37

$10.50 discount

UndervaluedFair: $39.87Overvalued
VTRSSignificantly Overvalued (-81.4%)

Margin of Safety

-81.4%

Fair Value

$8.89

Current Price

$20.74

$11.85 premium

UndervaluedFair: $8.89Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMPH3 strengths · Avg: 8.7/10
EPS GrowthGrowth
135.1%10/10

Earnings expanding 135.1% YoY

P/E RatioValuation
13.1x8/10

Attractively priced relative to earnings

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

VTRS1 strengths · Avg: 8.0/10
Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

AMPH3 concerns · Avg: 2.7/10
Market CapQuality
$1.22B3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
2.772/10

Expensive relative to growth rate

VTRS4 concerns · Avg: 2.0/10
PEG RatioValuation
3.732/10

Expensive relative to growth rate

Return on EquityProfitability
-2.9%2/10

ROE of -2.9% — below average capital efficiency

Revenue GrowthGrowth
-0.3%2/10

Revenue declined 0.3%

EPS GrowthGrowth
-70.6%2/10

Earnings declined 70.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMPH

The strongest argument for AMPH centers on EPS Growth, P/E Ratio, Price/Book.

Bull Case : VTRS

The strongest argument for VTRS centers on Price/Book.

Bear Case : AMPH

The primary concerns for AMPH are Market Cap, Piotroski F-Score, PEG Ratio.

Bear Case : VTRS

The primary concerns for VTRS are PEG Ratio, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

AMPH profiles as a value stock while VTRS is a turnaround play — different risk/reward profiles.

AMPH carries more volatility with a beta of 0.94 — expect wider price swings.

AMPH is growing revenue faster at 8.2% — sustainability is the question.

VTRS generates stronger free cash flow (329M), providing more financial flexibility.

Bottom Line

AMPH scores higher overall (65/100 vs 40/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amphastar P

HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.

Viatris Inc

HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.

Visit Website →

Want to dig deeper into these stocks?